Premium
[P2–013]: B‐VITAMIN THERAPY LOWERS HOMOCYSTEINE AND IMPROVES SELECTIVE COGNITIVE OUTCOMES IN THE RANDOMIZED FAVORIT ANCILLARY COGNITIVE TRIAL
Author(s) -
Troen Aron M.,
Scott Tammy,
Rogers Gail,
Weiner Daniel E.,
Livingston Kara,
Selhub Jacob,
Jacques Paul F.,
Rosenberg Irwin H.
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.06.661
Subject(s) - medicine , cognitive decline , homocysteine , dementia , population , randomized controlled trial , placebo , hyperhomocysteinemia , b vitamins , cognitive test , physical therapy , cognition , disease , psychiatry , environmental health , pathology , alternative medicine
University of S~ao Paulo, S~ao Paulo, Brazil; Department & Institute of Psychiatry Faculty of Medicine University of S~ao Paulo, S~ao Paulo, Brazil; Laboratory of Neurosciences, Institute of Psychiatry, Faculty of Medicine, University of S~ao Paulo, S~ao Paulo, Brazil; Thomas Jefferson University College of Health Professions, Philadelphia, PA, USA; Johns Hopkins University School of Nursing, Baltimore, MD, USA; Laboratory of Neuroscience (LIM-27), Department and Institute of Psychiatry, Faculty of Medicine, University of S~ao Paulo, S~ao Paulo-SP, Brazil. Contact e-mail: xandamartini@usp.br